+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bone Marrow Transplantation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 190 Pages
  • December 2023
  • Region: Global
  • Fairfield Market Research
  • ID: 5913312
Description Jump to:
The global Bone Marrow Transplantation market is experiencing substantial growth, driven by the vital procedure of replacing damaged bone marrow stem cells with healthy tissue. Bone marrow, responsible for hematopoiesis, lymphocyte synthesis, and fat storage, plays a crucial role in treating advanced stages of leukemia, lymphomas, multiple myeloma, anemia, and other diseases. The market is estimated at $10.55 billion in 2024 and is expected reaching an estimated value of $12.99 billion by 2031.

Increasing Awareness and Healthcare Initiatives Drive Market Growth

The global Bone Marrow Transplantation market is witnessing significant growth due to the increasing awareness of the procedure and the proactive initiatives undertaken by healthcare practitioners. This growth is particularly driven by the rising prevalence of blood cancer and the accessibility of bone marrow transplantation therapy.

Key Drivers of the Bone Marrow Transplantation Market

Rising Adoption of Bone Marrow Transplantations

The adoption of bone marrow transplantation procedures has seen a remarkable surge in recent years, primarily due to the high patient survival rates associated with this treatment. Bone marrow transplantation stands as the most effective and reliable therapy choice for advanced leukemia and other blood cancers.

Increasing Prevalence of Cancers and Anemia

The global bone marrow transplant market is propelled by the increasing prevalence of cancer and anemia. Bone marrow transplantation is recommended to treat advanced stages of blood cancer, sickle cell anemia, and various chronic diseases, further contributing to market growth.

Technological Advancements

Technological advancements and improved healthcare infrastructure are expected to be significant driving forces behind market growth. Ongoing research activities and a rise in product launches will further enhance market expansion during the forecast period.

Competitive Landscape

The Bone Marrow Transplantation market is highly competitive, featuring several major players who are continuously striving to increase their global market presence. These market leaders are actively engaged in various product launches and development activities with a focus on orthopedic surgical treatments.

Key Companies in the Bone Marrow Transplantation Market

  • Merck Millipore Corporation
  • Sanofi-Aventis LLC.
  • STEMCELL Technologies.
  • American Type Culture Collection (ATCC) Inc
  • ReeLabs Pvt. Ltd.
  • HemaCare

Bone Marrow Transplantation Market Categorization

Bone Marrow Transplantation Market by End User

  • Hospitals
  • Multispecialty Clinics
  • Ambulatory Surgical Centers

Bone Marrow Transplantation Market by Transplant Type

  • Autologous Bone Marrow Transplant
  • Allogeneic Bone marrow Transplant

Bone Marrow Transplantation Market by Disease Indication

  • Leukemia
  • Lymphoma
  • Myeloma
  • Others

Bone Marrow Transplantation Market by Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Bone Marrow Transplantation Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Bone Marrow Transplantation Market Outlook, 2018 - 2031
3.1. Global Bone Marrow Transplantation Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Hospitals
3.1.1.2. Multispecialty Clinics
3.1.1.3. Ambulatory Surgical Centers
3.2. Global Bone Marrow Transplantation Market Outlook, by Transplant Type, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Autologous Bone Marrow Transplant
3.2.1.2. Allogeneic Bone Marrow Transplant
3.3. Global Bone Marrow Transplantation Market Outlook, by Disease Indication, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Leukemia
3.3.1.2. Lymphoma
3.3.1.3. Myeloma
3.3.1.4. Others
3.4. Global Bone Marrow Transplantation Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Bone Marrow Transplantation Market Outlook, 2018 - 2031
4.1. North America Bone Marrow Transplantation Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Hospitals
4.1.1.2. Multispecialty Clinics
4.1.1.3. Ambulatory Surgical Centers
4.2. North America Bone Marrow Transplantation Market Outlook, by Transplant Type, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Autologous Bone Marrow Transplant
4.2.1.2. Allogeneic Bone Marrow Transplant
4.3. North America Bone Marrow Transplantation Market Outlook, by Disease Indication, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Leukemia
4.3.1.2. Lymphoma
4.3.1.3. Myeloma
4.3.1.4. Others
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Bone Marrow Transplantation Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. U.S. Bone Marrow Transplantation Market by End User, Value (US$ Bn), 2018 - 2031
4.4.1.2. U.S. Bone Marrow Transplantation Market by Transplant Type, Value (US$ Bn), 2018 - 2031
4.4.1.3. U.S. Bone Marrow Transplantation Market by Disease Indication, Value (US$ Bn), 2018 - 2031
4.4.1.4. Canada Bone Marrow Transplantation Market by End User, Value (US$ Bn), 2018 - 2031
4.4.1.5. Canada Bone Marrow Transplantation Market by Transplant Type, Value (US$ Bn), 2018 - 2031
4.4.1.6. Canada Bone Marrow Transplantation Market by Disease Indication, Value (US$ Bn), 2018 - 2031
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Bone Marrow Transplantation Market Outlook, 2018 - 2031
5.1. Europe Bone Marrow Transplantation Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Hospitals
5.1.1.2. Multispecialty Clinics
5.1.1.3. Ambulatory Surgical Centers
5.2. Europe Bone Marrow Transplantation Market Outlook, by Transplant Type, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Autologous Bone Marrow Transplant
5.2.1.2. Allogeneic Bone Marrow Transplant
5.3. Europe Bone Marrow Transplantation Market Outlook, by Disease Indication, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Leukemia
5.3.1.2. Lymphoma
5.3.1.3. Myeloma
5.3.1.4. Others
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Bone Marrow Transplantation Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Germany Bone Marrow Transplantation Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.2. Germany Bone Marrow Transplantation Market by Transplant Type, Value (US$ Bn), 2018 - 2031
5.4.1.3. Germany Bone Marrow Transplantation Market by Disease Indication, Value (US$ Bn), 2018 - 2031
5.4.1.4. U.K. Bone Marrow Transplantation Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.5. U.K. Bone Marrow Transplantation Market by Transplant Type, Value (US$ Bn), 2018 - 2031
5.4.1.6. U.K. Bone Marrow Transplantation Market by Disease Indication, Value (US$ Bn), 2018 - 2031
5.4.1.7. France Bone Marrow Transplantation Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.8. France Bone Marrow Transplantation Market by Transplant Type, Value (US$ Bn), 2018 - 2031
5.4.1.9. France Bone Marrow Transplantation Market by Disease Indication, Value (US$ Bn), 2018 - 2031
5.4.1.10. Italy Bone Marrow Transplantation Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.11. Italy Bone Marrow Transplantation Market by Transplant Type, Value (US$ Bn), 2018 - 2031
5.4.1.12. Italy Bone Marrow Transplantation Market by Disease Indication, Value (US$ Bn), 2018 - 2031
5.4.1.13. Turkey Bone Marrow Transplantation Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.14. Turkey Bone Marrow Transplantation Market by Transplant Type, Value (US$ Bn), 2018 - 2031
5.4.1.15. Turkey Bone Marrow Transplantation Market by Disease Indication, Value (US$ Bn), 2018 - 2031
5.4.1.16. Russia Bone Marrow Transplantation Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.17. Russia Bone Marrow Transplantation Market by Transplant Type, Value (US$ Bn), 2018 - 2031
5.4.1.18. Russia Bone Marrow Transplantation Market by Disease Indication, Value (US$ Bn), 2018 - 2031
5.4.1.19. Rest of Europe Bone Marrow Transplantation Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.20. Rest of Europe Bone Marrow Transplantation Market by Transplant Type, Value (US$ Bn), 2018 - 2031
5.4.1.21. Rest of Europe Bone Marrow Transplantation Market by Disease Indication, Value (US$ Bn), 2018 - 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Bone Marrow Transplantation Market Outlook, 2018 - 2031
6.1. Asia Pacific Bone Marrow Transplantation Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Hospitals
6.1.1.2. Multispecialty Clinics
6.1.1.3. Ambulatory Surgical Centers
6.2. Asia Pacific Bone Marrow Transplantation Market Outlook, by Transplant Type, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Autologous Bone Marrow Transplant
6.2.1.2. Allogeneic Bone Marrow Transplant
6.3. Asia Pacific Bone Marrow Transplantation Market Outlook, by Disease Indication, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Leukemia
6.3.1.2. Lymphoma
6.3.1.3. Myeloma
6.3.1.4. Others
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Bone Marrow Transplantation Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. China Bone Marrow Transplantation Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.2. China Bone Marrow Transplantation Market by Transplant Type, Value (US$ Bn), 2018 - 2031
6.4.1.3. China Bone Marrow Transplantation Market by Disease Indication, Value (US$ Bn), 2018 - 2031
6.4.1.4. Japan Bone Marrow Transplantation Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.5. Japan Bone Marrow Transplantation Market by Transplant Type, Value (US$ Bn), 2018 - 2031
6.4.1.6. Japan Bone Marrow Transplantation Market by Disease Indication, Value (US$ Bn), 2018 - 2031
6.4.1.7. South Korea Bone Marrow Transplantation Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.8. South Korea Bone Marrow Transplantation Market by Transplant Type, Value (US$ Bn), 2018 - 2031
6.4.1.9. South Korea Bone Marrow Transplantation Market by Disease Indication, Value (US$ Bn), 2018 - 2031
6.4.1.10. India Bone Marrow Transplantation Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.11. India Bone Marrow Transplantation Market by Transplant Type, Value (US$ Bn), 2018 - 2031
6.4.1.12. India Bone Marrow Transplantation Market by Disease Indication, Value (US$ Bn), 2018 - 2031
6.4.1.13. Southeast Asia Bone Marrow Transplantation Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.14. Southeast Asia Bone Marrow Transplantation Market by Transplant Type, Value (US$ Bn), 2018 - 2031
6.4.1.15. Southeast Asia Bone Marrow Transplantation Market by Disease Indication, Value (US$ Bn), 2018 - 2031
6.4.1.16. Rest of Asia Pacific Bone Marrow Transplantation Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.17. Rest of Asia Pacific Bone Marrow Transplantation Market by Transplant Type, Value (US$ Bn), 2018 - 2031
6.4.1.18. Rest of Asia Pacific Bone Marrow Transplantation Market by Disease Indication, Value (US$ Bn), 2018 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Bone Marrow Transplantation Market Outlook, 2018 - 2031
7.1. Latin America Bone Marrow Transplantation Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Hospitals
7.1.1.2. Multispecialty Clinics
7.1.1.3. Ambulatory Surgical Centers
7.2. Latin America Bone Marrow Transplantation Market Outlook, by Transplant Type, Value (US$ Bn), 2018 - 2031
7.2.1.1. Autologous Bone Marrow Transplant
7.2.1.2. Allogeneic Bone Marrow Transplant
7.3. Latin America Bone Marrow Transplantation Market Outlook, by Disease Indication, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Leukemia
7.3.1.2. Lymphoma
7.3.1.3. Myeloma
7.3.1.4. Others
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Bone Marrow Transplantation Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Brazil Bone Marrow Transplantation Market by End User, Value (US$ Bn), 2018 - 2031
7.4.1.2. Brazil Bone Marrow Transplantation Market by Transplant Type, Value (US$ Bn), 2018 - 2031
7.4.1.3. Brazil Bone Marrow Transplantation Market by Disease Indication, Value (US$ Bn), 2018 - 2031
7.4.1.4. Mexico Bone Marrow Transplantation Market by End User, Value (US$ Bn), 2018 - 2031
7.4.1.5. Mexico Bone Marrow Transplantation Market by Transplant Type, Value (US$ Bn), 2018 - 2031
7.4.1.6. Mexico Bone Marrow Transplantation Market by Disease Indication, Value (US$ Bn), 2018 - 2031
7.4.1.7. Argentina Bone Marrow Transplantation Market by End User, Value (US$ Bn), 2018 - 2031
7.4.1.8. Argentina Bone Marrow Transplantation Market by Transplant Type, Value (US$ Bn), 2018 - 2031
7.4.1.9. Argentina Bone Marrow Transplantation Market by Disease Indication, Value (US$ Bn), 2018 - 2031
7.4.1.10. Rest of Latin America Bone Marrow Transplantation Market by End User, Value (US$ Bn), 2018 - 2031
7.4.1.11. Rest of Latin America Bone Marrow Transplantation Market by Transplant Type, Value (US$ Bn), 2018 - 2031
7.4.1.12. Rest of Latin America Bone Marrow Transplantation Market by Disease Indication, Value (US$ Bn), 2018 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Bone Marrow Transplantation Market Outlook, 2018 - 2031
8.1. Middle East & Africa Bone Marrow Transplantation Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Hospitals
8.1.1.2. Multispecialty Clinics
8.1.1.3. Ambulatory Surgical Centers
8.2. Middle East & Africa Bone Marrow Transplantation Market Outlook, by Transplant Type, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Autologous Bone Marrow Transplant
8.2.1.2. Allogeneic Bone Marrow Transplant
8.3. Middle East & Africa Bone Marrow Transplantation Market Outlook, by Disease Indication, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Leukemia
8.3.1.2. Lymphoma
8.3.1.3. Myeloma
8.3.1.4. Others
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Bone Marrow Transplantation Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. GCC Bone Marrow Transplantation Market by End User, Value (US$ Bn), 2018 - 2031
8.4.1.2. GCC Bone Marrow Transplantation Market by Transplant Type, Value (US$ Bn), 2018 - 2031
8.4.1.3. GCC Bone Marrow Transplantation Market by Disease Indication, Value (US$ Bn), 2018 - 2031
8.4.1.4. South Africa Bone Marrow Transplantation Market by End User, Value (US$ Bn), 2018 - 2031
8.4.1.5. South Africa Bone Marrow Transplantation Market by Transplant Type, Value (US$ Bn), 2018 - 2031
8.4.1.6. South Africa Bone Marrow Transplantation Market by Disease Indication, Value (US$ Bn), 2018 - 2031
8.4.1.7. Egypt Bone Marrow Transplantation Market by End User, Value (US$ Bn), 2018 - 2031
8.4.1.8. Egypt Bone Marrow Transplantation Market by Transplant Type, Value (US$ Bn), 2018 - 2031
8.4.1.9. Egypt Bone Marrow Transplantation Market by Disease Indication, Value (US$ Bn), 2018 - 2031
8.4.1.10. Nigeria Bone Marrow Transplantation Market by End User, Value (US$ Bn), 2018 - 2031
8.4.1.11. Nigeria Bone Marrow Transplantation Market by Transplant Type, Value (US$ Bn), 2018 - 2031
8.4.1.12. Nigeria Bone Marrow Transplantation Market by Disease Indication, Value (US$ Bn), 2018 - 2031
8.4.1.13. Rest of Middle East & Africa Bone Marrow Transplantation Market by End User, Value (US$ Bn), 2018 - 2031
8.4.1.14. Rest of Middle East & Africa Bone Marrow Transplantation Market by Transplant Type, Value (US$ Bn), 2018 - 2031
8.4.1.15. Rest of Middle East & Africa Bone Marrow Transplantation Market by Disease Indication, Value (US$ Bn), 2018 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Segment 3 vs by Transplant Type Heat map
9.2. Manufacturer vs by Transplant Type Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Lonza Group Ltd.
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Merck Millipore Corporation
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Sanofi-Aventis LLC.
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. STEMCELL Technologies.
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. American Type Culture Collection (ATCC) Inc
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. ReeLabs Pvt. Ltd.
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. HemaCare
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Lonza Group Ltd.
  • Merck Millipore Corporation
  • Sanofi-Aventis LLC.
  • STEMCELL Technologies.
  • American Type Culture Collection (ATCC) Inc
  • ReeLabs Pvt. Ltd.
  • HemaCare

Methodology

Loading
LOADING...

Related Topics

Related Reports

Bone Marrow Transplantation Global Market Report 2024 - Product Image

Bone Marrow Transplantation Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Global Bone Marrow Transplantation Market by Type (Allogeneic Transplant, Autologous Transplant), Treatment Type (Aplastic Anemia, Leukemia, Lymphoma), End-User - Forecast 2024-2030 - Product Image

Global Bone Marrow Transplantation Market by Type (Allogeneic Transplant, Autologous Transplant), Treatment Type (Aplastic Anemia, Leukemia, Lymphoma), End-User - Forecast 2024-2030

  • Report
  • 196 Pages
  • Global
From
Hematopoietic Stem Cell Transplantation - Pipeline Insight, 2024 - Product Image

Hematopoietic Stem Cell Transplantation - Pipeline Insight, 2024

  • Clinical Trials
  • 80 Pages
  • Global
From
Hematopoietic Stem Cell Transplantation Global Market Report 2024 - Product Image

Hematopoietic Stem Cell Transplantation Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Bone Marrow Transplant Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Bone Marrow Transplant Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 92 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.